Does rosuvastatin (statin) cause constipation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Does Rosuvastatin Cause Constipation?

Yes, rosuvastatin can cause constipation as a side effect, occurring in approximately 2.4% of patients taking the medication compared to 2.0% in placebo groups. 1

Evidence from Drug Labeling

Rosuvastatin's FDA-approved drug label specifically lists constipation as one of the common side effects:

  • Constipation was reported in 2.4% of patients taking rosuvastatin in placebo-controlled trials, compared to 2.0% in those taking placebo 1
  • In the JUPITER study (a large clinical trial evaluating rosuvastatin 20mg), constipation was reported in 3.3% of patients taking rosuvastatin compared to 3.0% in the placebo group 1
  • Constipation is listed among the "most common side effects" in the patient information section of the drug label, along with headache, nausea, muscle aches and pains, and weakness 1

Pharmacokinetics and Mechanism

Rosuvastatin's pharmacological properties may contribute to its gastrointestinal side effects:

  • Rosuvastatin is a hydrophilic statin that undergoes minimal metabolism by the cytochrome P450 system, with only about 10% renal excretion 2, 3
  • It has a longer half-life (19 hours) compared to many other statins, which might contribute to its side effect profile 2
  • Unlike some other statins, rosuvastatin is not extensively metabolized in the liver, which may affect how it interacts with the gastrointestinal system 3

Clinical Significance

The constipation associated with rosuvastatin is generally:

  • Mild to moderate in severity 4
  • Often transient and self-limiting 4
  • Manageable with standard constipation treatments when necessary 2
  • Rarely a cause for discontinuation of therapy 5

Management of Statin-Associated Constipation

If constipation occurs while taking rosuvastatin:

  • Increasing fluid intake and physical activity should be encouraged when appropriate 2
  • A stimulating laxative may be used to increase bowel motility 2
  • For persistent constipation, adding other laxatives may be considered, such as polyethylene glycol, lactulose, or magnesium citrate 2
  • Severe or persistent constipation should prompt evaluation for other causes, as statins are rarely the sole cause of significant constipation 2

Important Considerations

  • The risk of constipation should be weighed against the cardiovascular benefits of statin therapy 2
  • Constipation is generally considered a minor side effect compared to other potential statin adverse effects such as myopathy 6
  • In rare cases, severe constipation may be a sign of a more serious condition like ischemic colitis, which has been reported with rosuvastatin (though extremely rare) 7
  • Patients with pre-existing gastrointestinal conditions may be more susceptible to constipation while taking rosuvastatin 6

Comparative Incidence with Other Statins

  • The incidence of constipation appears similar across different statins, suggesting this is likely a class effect rather than specific to rosuvastatin 4, 8
  • There is no strong evidence suggesting that rosuvastatin causes more constipation than other statins at equivalent doses 5, 4

When prescribing rosuvastatin, patients should be informed about the possibility of constipation as a side effect, but reassured that it is typically mild, manageable, and should not deter them from taking this important medication for cardiovascular risk reduction.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Statins with Less Hepatic Metabolism

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Rosuvastatin: a review of its use in the management of dyslipidemia.

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2004

Research

Rosuvastatin-associated adverse effects and drug-drug interactions in the clinical setting of dyslipidemia.

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2010

Research

Rosuvastatin.

Drugs, 2002

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.